Private Capital Group’s MacroGenics MGNX Stock Holding History

Private Capital Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24	Closed	–	–	2067
2019 Q4	$0	Hold	24	–	–	﹤0.01%	2114
2019 Q3	$0	Buy	+24	New	+$346	﹤0.01%	2377
2019 Q2	–	Sell	-24	Closed	–	–	2336
2019 Q1	$0	Hold	24	–	–	﹤0.01%	2273
2018 Q4	$0	Buy	+24	New	+$402	﹤0.01%	2291

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Private Capital Group's MGNX Position: Q1 2020 in Review

Private Capital Group sold out of MacroGenics (MGNX) in Q1 2020, closing a stake of 24 shares.

Private Capital Group first reported a position in MGNX in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 122 funds tracked by Wall St. Rank hold MGNX as of Q1 2020.

Private Capital Group reported no remaining MacroGenics position as of Q1 2020 after selling out during the quarter.
Private Capital Group sold 24 MacroGenics shares in Q1 2020.
Private Capital Group first reported a position in MacroGenics in Q4 2018 and held it in 4 quarters.
Private Capital Group's MacroGenics position peaked at $0 in Q4 2019.
122 funds tracked by Wall St. Rank held MacroGenics as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.